NO20064048L - Ny assosiasjon mellom agomelatin og en nordadrenalin-reopptaksinhibitor, og farmasoytiske sammensetninger inneholdende den - Google Patents

Ny assosiasjon mellom agomelatin og en nordadrenalin-reopptaksinhibitor, og farmasoytiske sammensetninger inneholdende den

Info

Publication number
NO20064048L
NO20064048L NO20064048A NO20064048A NO20064048L NO 20064048 L NO20064048 L NO 20064048L NO 20064048 A NO20064048 A NO 20064048A NO 20064048 A NO20064048 A NO 20064048A NO 20064048 L NO20064048 L NO 20064048L
Authority
NO
Norway
Prior art keywords
agomelatine
northern
reuptake inhibitor
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO20064048A
Other languages
English (en)
Other versions
NO338029B1 (no
Inventor
Elisabeth Mocaer
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20064048L publication Critical patent/NO20064048L/no
Publication of NO338029B1 publication Critical patent/NO338029B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Assosiasjon omfattende agomelatin, eller iV-[2-(7-metoksy-l-naftyl)etyl]acetamid, i assosiasjon med et noradrenalin-reopptaksinhibitormiddel. Bruk av en slik assosiasjon i fremstillingen av et medikament fior bruk mot depresjoner.
NO20064048A 2005-09-09 2006-09-08 Blanding mellom agomelatin og reboxetin til fremstilling av medikamenter mot depresjon og sinnsstemningslidelser NO338029B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0509206A FR2890564B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
NO20064048L true NO20064048L (no) 2007-03-12
NO338029B1 NO338029B1 (no) 2016-07-25

Family

ID=36190808

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064048A NO338029B1 (no) 2005-09-09 2006-09-08 Blanding mellom agomelatin og reboxetin til fremstilling av medikamenter mot depresjon og sinnsstemningslidelser

Country Status (40)

Country Link
US (1) US7622505B2 (no)
EP (1) EP1769798B1 (no)
JP (2) JP5395998B2 (no)
KR (1) KR100863384B1 (no)
CN (1) CN1927205A (no)
AP (1) AP2615A (no)
AR (1) AR056056A1 (no)
AT (1) ATE404205T1 (no)
AU (1) AU2006209368B2 (no)
BR (1) BRPI0603759A (no)
CA (1) CA2558782C (no)
CY (1) CY1108319T1 (no)
DE (1) DE602006002210D1 (no)
DK (1) DK1769798T3 (no)
EA (1) EA011650B1 (no)
ES (1) ES2313590T3 (no)
FR (1) FR2890564B1 (no)
GE (1) GEP20094742B (no)
GT (1) GT200600408A (no)
HR (1) HRP20080535T3 (no)
JO (1) JO2521B1 (no)
MA (1) MA28505B1 (no)
ME (2) ME02767B (no)
MX (1) MXPA06010157A (no)
MY (1) MY142260A (no)
NO (1) NO338029B1 (no)
NZ (1) NZ549725A (no)
PE (1) PE20070429A1 (no)
PL (1) PL1769798T3 (no)
PT (1) PT1769798E (no)
PY (1) PY0626552A (no)
RS (1) RS50631B (no)
SA (1) SA06270308B1 (no)
SG (1) SG131030A1 (no)
SI (1) SI1769798T1 (no)
TW (1) TWI324513B (no)
UA (1) UA83542C2 (no)
UY (1) UY29778A1 (no)
WO (1) WO2007028904A1 (no)
ZA (1) ZA200607562B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008137461A1 (en) * 2007-05-01 2008-11-13 Concert Pharmaceuticals Inc. Naphthyl(ethyl) acetamides
US20080280991A1 (en) * 2007-05-08 2008-11-13 Auspex Pharmaceuticals, Inc. Substituted naphthalenes
CN102342924A (zh) * 2010-08-05 2012-02-08 北京本草天源药物研究院 一种含有阿戈美拉汀的药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
WO1999020279A1 (en) * 1997-10-17 1999-04-29 Eli Lilly And Company Potentiation of pharmaceuticals
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
IL163720A0 (en) * 2002-02-26 2005-12-18 Ortho Mcneil Pharm Inc Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
JP2004292445A (ja) * 2003-03-11 2004-10-21 Katsunori Nonogaki 糖尿病治療薬
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
KR20060087560A (ko) * 2003-09-12 2006-08-02 워너-램버트 캄파니 엘엘씨 알파-2-델타 리간드 및 ｓｓｒｉ 및/또는 ｓｎｒｉ를포함하는 우울증 및 불안 장애 치료용 조합물

Also Published As

Publication number Publication date
UY29778A1 (es) 2006-10-31
JO2521B1 (en) 2010-03-17
JP5395998B2 (ja) 2014-01-22
GT200600408A (es) 2007-05-21
AR056056A1 (es) 2007-09-12
CY1108319T1 (el) 2014-02-12
EP1769798A1 (fr) 2007-04-04
SG131030A1 (en) 2007-04-26
EA011650B1 (ru) 2009-04-28
KR100863384B1 (ko) 2008-10-13
ZA200607562B (en) 2008-05-28
FR2890564A1 (fr) 2007-03-16
KR20070029606A (ko) 2007-03-14
MXPA06010157A (es) 2007-03-08
NZ549725A (en) 2008-03-28
ME02767B (me) 2010-06-30
MY142260A (en) 2010-11-15
CN1927205A (zh) 2007-03-14
TWI324513B (en) 2010-05-11
TW200744570A (en) 2007-12-16
SI1769798T1 (sl) 2008-12-31
AU2006209368A1 (en) 2007-03-29
CA2558782A1 (fr) 2007-03-09
US7622505B2 (en) 2009-11-24
EP1769798B1 (fr) 2008-08-13
ATE404205T1 (de) 2008-08-15
BRPI0603759A (pt) 2007-05-15
AP2615A (en) 2013-03-14
AP2008004378A0 (en) 2008-04-30
MA28505B1 (fr) 2007-04-03
WO2007028904A1 (fr) 2007-03-15
DK1769798T3 (da) 2008-11-24
PE20070429A1 (es) 2007-06-02
NO338029B1 (no) 2016-07-25
FR2890564B1 (fr) 2007-10-19
DE602006002210D1 (de) 2008-09-25
AU2006209368B2 (en) 2012-07-19
GEP20094742B (en) 2009-07-27
SA06270308B1 (ar) 2011-10-08
ME02758B (me) 2010-06-30
CA2558782C (fr) 2012-05-15
PY0626552A (es) 2011-01-03
PL1769798T3 (pl) 2008-12-31
UA83542C2 (uk) 2008-07-25
HRP20080535T3 (en) 2008-12-31
ES2313590T3 (es) 2009-03-01
PT1769798E (pt) 2008-09-18
US20070060654A1 (en) 2007-03-15
RS50631B (sr) 2010-06-30
JP2007077147A (ja) 2007-03-29
EA200601410A1 (ru) 2007-04-27
JP2011088919A (ja) 2011-05-06

Similar Documents

Publication Publication Date Title
UY28330A1 (es) Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
BRPI0113669B8 (pt) n-hidróxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil]-amino]metil]fenil]-2e-2-propenamida, composição farmacêutica compreendendo o mesmo e uso
NO20053088L (no) Farmasoytisk preparat inneholdende en beta-3-adrenoseptoragonist og en serotonin og/eller norepinefrin-gjenopptakelsesinhibitor og anvendelse av nevnte preparat for behandling av blaeredysfunksjon.
NO20161808A1 (no) Sammensetninger omfattende ornitin og fenylacetat eller fenylbutyrat for å behandle hepatisk encefalopati
BRPI0412054A (pt) preparação farmacêutica transdérmica
GEP20053652B (en) Salts of A Isothiazole-4-Carboxamide and their Use as Anti-Hyperproliferation Agents
BRPI0701601A (pt) uso de agomelatina na obtenção de medicamentos previstos para o tratamento do dirtúrbio de ansiedade generalizada
CL2009000980A1 (es) Uso de (s)-n-(2-(1,6,8-tetrahidro-2h-inden[5,4-b]furan-8-il)etil]propionamida en combinacion con una o más drogas seleccionadas de un grupo definido para preparar un medicamento útil para la prevencion o tratamiento de la depresión o desórdenes de ansiedad (divisional de la solicitud 749-2006).
NO20064050L (no) Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av sovnforstyrrelser i den deprimerte pasient
NO20075989L (no) Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av Smith-Magenis syndrom
TNSN07364A1 (en) Use of agomelatine for obtaining medicaments used for treating bipolar disorders
HRP20080178T3 (hr) Farmaceutski pripravak u obliku hidrogela za transdermalnu primjenu aktivnih tvari
EA200601410A1 (ru) Новая комбинация агомелатина и ингибитора обратного поглощения норадреналина и фармацевтические композиции, которые её содержат
NO20076002L (no) Anvendelse av agomelatin for a oppna medikamenter tiltenkt for behandlingen av periventrikulaer levkomalasi
NO20064049L (no) Ny assosiasjon mellom agomelatin og et tymoregulerende middel og farmasoytiske sammensetninger inneholdende den
EA201201286A1 (ru) Новое биологически активное соединение n-[3-(нитрофениламино)индол-2-илметилен]аминогуанидина гидрохлорид с противовоспалительной активностью
NO20081723L (no) Assosiasjon av beta 3 reseotoragonist og monoamin gjenopptaksinhibator, farmasoytisk sammensetting inneholdende samme og terapeutisk anvendelse derav
CU20070232A7 (es) Utilización de la agomelatina para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees